Zhaoke Ophthalmology Limited
Zhaoke Ophthalmology Limited (6622.HK) Company Profile & Overview
Explore Zhaoke Ophthalmology Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Zhaoke Ophthalmology Limited (6622.HK) Company Profile & Overview
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.